{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:25:12Z","timestamp":1787617512025,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jaad.2015.09.056","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T09:01:47Z","timestamp":1452934907000},"page":"280-287.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis"],"prefix":"10.1016","volume":"74","author":[{"given":"Amy S.","family":"Paller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara Creamer","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Kricorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.09.056_bib1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","article-title":"Incidence of psoriasis in children: a population-based study","volume":"62","author":"Tollefson","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","article-title":"The natural history of psoriasis in 5,600 patients","volume":"148","author":"Farber","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2015.09.056_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1525-1470.2000.01746.x","article-title":"A comparative study of pediatric onset psoriasis with adult onset psoriasis","volume":"17","author":"Raychaudhuri","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archdermatol.2011.263","article-title":"Trends in pediatric psoriasis outpatient health care delivery in the United States","volume":"148","author":"Vogel","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/ejd.2014.2291","article-title":"Cardiovascular comorbidities in childhood psoriasis","volume":"24","author":"Torres","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00431-011-1587-2","article-title":"Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases","volume":"171","author":"Varni","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2015.09.056_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1525-1470.2010.01195.x","article-title":"Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis","volume":"27","author":"Bilgic","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ad.2013.02.009","article-title":"Cumulative life course impairment: the imprint of psoriasis on the patient's life","volume":"105","author":"Ros","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2015.09.056_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jdv.12749","article-title":"Systemic treatments in paediatric psoriasis: a systematic evidence-based update","volume":"29","author":"van Geel","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.09.056_bib11","series-title":"Enbrel (etanercept) [prescribing information]","year":"2015"},{"key":"10.1016\/j.jaad.2015.09.056_bib12","first-page":"35","article-title":"Clinical utility of etanercept in the treatment of arthritides in children and adolescents","volume":"5","author":"Dore","year":"2014","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.jaad.2015.09.056_bib13","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","article-title":"Long-term safety and\u00a0effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis","volume":"60","author":"Giannini","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2015.09.056_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.09.056_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","article-title":"Long-term etanercept in pediatric patients with plaque psoriasis","volume":"63","author":"Paller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib16","unstructured":"Centers for Disease Control and Prevention. Growth charts: percentile data files with LMS values. Available from: URL: http:\/\/www.cdc.gov\/growthcharts\/percentile_data_files.htm. Accessed March 4, 2015."},{"key":"10.1016\/j.jaad.2015.09.056_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2133.2009.09276.x","article-title":"Overweight and childhood psoriasis","volume":"161","author":"Boccardi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpeds.2011.03.006","article-title":"The association of psoriasis and elevated blood lipids in overweight and obese children","volume":"159","author":"Koebnick","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2015.09.056_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1346-8138.2011.01281.x","article-title":"Relationship of the body mass index and childhood psoriasis in a Chinese Han population: a hospital-based study","volume":"39","author":"Zhu","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib20","first-page":"1","article-title":"Safety of TNF inhibitors in adolescents and children","volume":"2","author":"McCluggage","year":"2011","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.jaad.2015.09.056_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.09.056_bib22","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","article-title":"Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2015.09.056_bib23","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2015.09.056_bib24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","article-title":"Factors associated with treatment response to etanercept in juvenile idiopathic arthritis","volume":"306","author":"Otten","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2015.09.056_bib25","doi-asserted-by":"crossref","first-page":"SR35","DOI":"10.12659\/MSM.882109","article-title":"Etanercept treatment in juvenile idiopathic arthritis: the Polish registry","volume":"17","author":"Zuber","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaad.2015.09.056_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","article-title":"Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting","volume":"54","author":"Tarkiainen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2015.09.056_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2015.09.056_bib28","first-page":"928","article-title":"Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study","volume":"9","author":"Leonardi","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2015.09.056_bib29","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jaad.2010.07.026","article-title":"Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population","volume":"66","author":"Papp","year":"2012","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215022707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215022707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:10Z","timestamp":1759271950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215022707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0190962215022707"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.09.056","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726110444.793516895","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726110444.793516167","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.09.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}